Latest News

First Omicron variant case identified in U.S.


 

The first case of the Omicron variant of the coronavirus in the United States was confirmed by officials today in an individual in California who had recently traveled to South Africa. He or she was fully vaccinated against COVID-19 and experienced only “mild symptoms that are improving,” officials with the Centers for Disease Control and Prevention said.

The patient, who was not named in the CDC’s announcement of the first U.S. case of the Omicron variant Dec. 1, is self-quarantining.

“All close contacts have been contacted and have tested negative,” officials said.

The announcement comes as no surprise to many as the Omicron variant, first identified in South Africa, has been reported in countries around the world in recent days. Hong Kong, the United Kingdom, and Germany each reported this variant, as have Italy and the Netherlands. Over the weekend, the first North American cases were identified in Canada.

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, announced over the weekend that this newest variant was likely already in the United States, telling ABC’s This Week its appearance here was “inevitable.”

Similar to previous variants, this new strain likely started circulating in the United States before scientists could do genetic tests to confirm its presence.

The World Health Organization named Omicron a “variant of concern” on Nov. 26, even though much remains unknown about how well it spreads, how severe it can be, and how it may resist vaccines. In the meantime, the United States enacted travel bans from multiple South African countries.

It remains to be seen if Omicron will follow the pattern of the Delta variant, which was first identified in the United States in May and became the dominant strain by July. It’s also possible it will follow the path taken by the Mu variant. Mu emerged in March and April to much concern, only to fizzle out by September because it was unable to compete with the Delta variant.

A version of this article first appeared on WebMD.com.

Recommended Reading

‘Misleading’ results in colchicine COVID-19 trials meta-analysis
MDedge Infectious Disease
Children and COVID: New cases increase for third straight week
MDedge Infectious Disease
30% of docs say they don’t want own kids 5-11 to get COVID vaccine
MDedge Infectious Disease
Fueling an ‘already raging fire’: Fifth COVID surge approaches
MDedge Infectious Disease
Pfizer COVID vaccine is 100% effective in adolescents: Study
MDedge Infectious Disease
Merck’s COVID-19 pill may be less effective than first hoped
MDedge Infectious Disease
FDA panel backs first pill for COVID-19 by a small margin
MDedge Infectious Disease
Fauci: Omicron ‘very different from other variants’
MDedge Infectious Disease
Children and COVID: New cases, vaccinations both decline
MDedge Infectious Disease
Moderna warns of material drop in vaccine efficacy against Omicron
MDedge Infectious Disease